PL
GILD icon

Plancorp LLC’s Gilead Sciences GILD Stock Holding History

Plancorp LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$861K Buy
6,551
+440
+7% +$58K 0.02% 198
2026
Q1 		$849K Buy
6,111
+50
+0.8% +$7K 0.02% 165
2025
Q4 		$744K Sell
6,061
-246
-4% -$29.9K 0.02% 179
2025
Q3 		$700K Sell
6,307
-100
-2% -$11.4K 0.02% 187
2025
Q2 		$710K Buy
6,407
+61
+1% +$6.49K 0.02% 186
2025
Q1 		$711K Buy
6,346
+292
+5% +$30.1K 0.03% 171
2024
Q4 		$559K Buy
6,054
+150
+3% +$13.5K 0.02% 184
2024
Q3 		$495K Buy
5,904
+193
+3% +$14.7K 0.02% 194
2024
Q2 		$392K Sell
5,711
-161
-3% -$10.7K 0.02% 203
2024
Q1 		$430K Buy
5,872
+188
+3% +$14.5K 0.02% 198
2023
Q4 		$460K Buy
5,684
+130
+2% +$10.1K 0.02% 174
2023
Q3 		$416K Buy
5,554
+299
+6% +$23K 0.02% 169
2023
Q2 		$405K Sell
5,255
-14
-0.3% -$1.12K 0.02% 164
2023
Q1 		$437K Buy
5,269
+3
+0.1% +$248 0.02% 165
2022
Q4 		$452K Buy
5,266
+22
+0.4% +$1.74K 0.03% 153
2022
Q3 		$324K Buy
5,244
+121
+2% +$7.63K 0.02% 172
2022
Q2 		$317K Buy
5,123
+236
+5% +$14.6K 0.02% 174
2022
Q1 		$291K Sell
4,887
-358
-7% -$22.9K 0.02% 201
2021
Q4 		$381K Buy
5,245
+32
+0.6% +$2.2K 0.02% 170
2021
Q3 		$364K Buy
5,213
+306
+6% +$21.5K 0.03% 164
2021
Q2 		$338K Sell
4,907
-408
-8% -$27.2K 0.03% 163
2021
Q1 		$344K Sell
5,315
-3
-0.1% -$193 0.08% 150
2020
Q4 		$310K Buy
5,318
+236
+5% +$14.2K 0.08% 155
2020
Q3 		$321K Buy
5,082
+498
+11% +$34.5K 0.1% 132
2020
Q2 		$353K Buy
4,584
+289
+7% +$22.1K 0.11% 123
2020
Q1 		$321K Buy
+4,295
New +$297K 0.12% 119
2019
Q2 		– Sell
-17,181
Closed -$1.12M – 175
2019
Q1 		$1.12M Buy
17,181
+426
+3% +$28.3K 0.42% 55
2018
Q4 		$1.05M Sell
16,755
-117
-0.7% -$8.18K 0.48% 50
2018
Q3 		$1.3M Hold
16,872
– – 0.51% 45
2018
Q2 		$1.2M Hold
16,872
– – 0.48% 47
2018
Q1 		$1.27M Hold
16,872
– – 0.41% 42
2017
Q4 		$1.21M Hold
16,872
– – 0.39% 47
2017
Q3 		$1.37M Sell
16,872
-1
-0% -$76 0.4% 41
2017
Q2 		$1.19M Sell
16,873
-544
-3% -$36.2K 0.35% 48
2017
Q1 		$1.18M Buy
17,417
+143
+0.8% +$10.1K 0.34% 48
2016
Q4 		$1.24M Sell
17,274
-713
-4% -$53K 0.35% 46
2016
Q3 		$1.42M Buy
17,987
+1,155
+7% +$93.8K 0.9% 31
2016
Q2 		$1.4M Buy
+16,832
New +$1.49M 1.25% 20
2016
Q1 		– Sell
-16,832
Closed -$1.7M – 57
2015
Q4 		$1.7M Hold
16,832
– – 2.03% 13
2015
Q3 		$1.65M Buy
+16,832
New +$1.87M 1.5% 15
2015
Q2 		– Sell
-18,336
Closed -$1.8M – 87
2015
Q1 		$1.8M Buy
+18,336
New +$1.86M 1.79% 8

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Plancorp LLC's GILD Position: Q2 2026 in Review

Plancorp LLC increased its Gilead Sciences (GILD) stake by 7.2% in Q2 2026, buying an estimated $58K and bringing the position to 6,551 shares worth $861K. The position accounts for 0.02% of the portfolio, ranked #198.

Plancorp LLC first reported a position in GILD in Q1 2015 and has held it in 41 quarters since. The position peaked at $1.8M in Q1 2015. 610 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Plancorp LLC held 6,551 shares of Gilead Sciences worth $861K as of Q2 2026.
  • Plancorp LLC bought 440 Gilead Sciences shares in Q2 2026, an estimated $58K.
  • Gilead Sciences made up 0.02% of Plancorp LLC's portfolio in Q2 2026, its #198 holding.
  • Plancorp LLC first reported a position in Gilead Sciences in Q1 2015 and has held it in 41 quarters since.
  • Plancorp LLC's Gilead Sciences position peaked at $1.8M in Q1 2015.
  • 610 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Plancorp LLC's 13F filing for Q2 2026, filed 14 Jul 2026.